KSI Fundamental Analysis - KNEAT.COM INC

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to KSI. KSI was compared to 9 industry peers in the Health Care Technology industry. KSI has an average financial health and profitability rating. KSI is valued quite expensively, but it does show have an excellent growth rating.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year KSI has reported negative net income.

KSI had a positive operating cash flow in the past year.

In the past 5 years KSI always reported negative net income.

The reported operating cash flow has been mixed in the past 5 years: KSI reported negative operating cash flow in multiple years.

1.2 Ratios

KSI has a Return On Assets of 0.35%. This is amongst the best in the industry. KSI outperforms 88.89% of its industry peers.

KSI has a better Return On Equity (0.72%) than 88.89% of its industry peers.

		Industry Rank	Sector Rank
ROA	0.35%
ROE	0.72%
ROIC	N/A

ROA(3y)-15.47%

ROA(5y)-16.49%

ROE(3y)-45.71%

ROE(5y)-39.12%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With an excellent Profit Margin value of 0.84%, KSI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.

Looking at the Gross Margin, with a value of 75.35%, KSI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.

In the last couple of years the Gross Margin of KSI has grown nicely.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	0.84%
GM	75.35%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.7%

GM growth 5Y11.01%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

KSI does not have a ROIC to compare to the WACC, probably because it is not profitable.

KSI has more shares outstanding than it did 1 year ago.

KSI has more shares outstanding than it did 5 years ago.

The debt/assets ratio for KSI has been reduced compared to a year ago.

2.2 Solvency

KSI has an Altman-Z score of 4.29. This indicates that KSI is financially healthy and has little risk of bankruptcy at the moment.

With a Altman-Z score value of 4.29, KSI perfoms like the industry average, outperforming 55.56% of the companies in the same industry.

A Debt/Equity ratio of 0.37 indicates that KSI is not too dependend on debt financing.

KSI has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: KSI outperforms 55.56% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.37
Debt/FCF	N/A
Altman-Z	4.29

ROIC/WACCN/A

WACC7.28%

2.3 Liquidity

KSI has a Current Ratio of 1.81. This is a normal value and indicates that KSI is financially healthy and should not expect problems in meeting its short term obligations.

The Current ratio of KSI (1.81) is better than 88.89% of its industry peers.

KSI has a Quick Ratio of 1.81. This is a normal value and indicates that KSI is financially healthy and should not expect problems in meeting its short term obligations.

With an excellent Quick ratio value of 1.81, KSI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	1.81
Quick Ratio	1.81

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KSI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 100.00%, which is quite impressive.

Looking at the last year, KSI shows a very strong growth in Revenue. The Revenue has grown by 39.32%.

The Revenue has been growing by 65.43% on average over the past years. This is a very strong growth!

EPS 1Y (TTM)100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

Revenue 1Y (TTM)39.32%

Revenue growth 3Y46.7%

Revenue growth 5Y65.43%

Sales Q2Q%31.94%

3.2 Future

Based on estimates for the next years, KSI will show a very strong growth in Earnings Per Share. The EPS will grow by 46.05% on average per year.

The Revenue is expected to grow by 30.40% on average over the next years. This is a very strong growth

EPS Next Y52.02%

EPS Next 2Y5.65%

EPS Next 3Y46.05%

EPS Next 5YN/A

Revenue Next Year31.7%

Revenue Next 2Y30.51%

Revenue Next 3Y33.84%

Revenue Next 5Y30.4%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Forward Price/Earnings Ratio is negative for KSI. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KSI indicates a somewhat cheap valuation: KSI is cheaper than 77.78% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	93.24

4.3 Compensation for Growth

KSI's earnings are expected to grow with 46.05% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y5.65%

EPS Next 3Y46.05%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for KSI!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KNEAT.COM INC

TSX:KSI (8/29/2025, 7:00:00 PM)

5.41

+0.23 (+4.44%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Technology

Earnings (Last)08-05 2025-08-05/amc

Earnings (Next)11-04 2025-11-04

Inst Owners13.73%

Inst Owner ChangeN/A

Ins Owners9.82%

Ins Owner ChangeN/A

Market Cap514.06M

Analysts80

Price Target8.06 (48.98%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)2

Avg EPS beat(2)139.6%

Min EPS beat(2)100%

Max EPS beat(2)179.21%

EPS beat(4)4

Avg EPS beat(4)100.76%

Min EPS beat(4)0.99%

Max EPS beat(4)179.21%

EPS beat(8)8

Avg EPS beat(8)55.69%

EPS beat(12)11

Avg EPS beat(12)42.49%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-5%

Min Revenue beat(2)-5.77%

Max Revenue beat(2)-4.23%

Revenue beat(4)1

Avg Revenue beat(4)-2.31%

Min Revenue beat(4)-5.77%

Max Revenue beat(4)2.47%

Revenue beat(8)3

Avg Revenue beat(8)-1.06%

Revenue beat(12)5

Avg Revenue beat(12)-0.58%

Revenue beat(16)9

Avg Revenue beat(16)3.48%

PT rev (1m)-3.66%

PT rev (3m)-5.39%

EPS NQ rev (1m)-49.98%

EPS NQ rev (3m)N/A

EPS NY rev (1m)42.42%

EPS NY rev (3m)42.42%

Revenue NQ rev (1m)-2%

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)-2.53%

Revenue NY rev (3m)-5%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	9.07
P/FCF	N/A
P/OCF	33.58
P/B	7.74
P/tB	21.09
EV/EBITDA	93.24

EPS(TTM)0

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)-0.06

FCFYN/A

OCF(TTM)0.16

OCFY2.98%

SpS0.6

BVpS0.7

TBVpS0.26

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	0.35%
ROE	0.72%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	0.84%
GM	75.35%
FCFM	N/A

ROA(3y)-15.47%

ROA(5y)-16.49%

ROE(3y)-45.71%

ROE(5y)-39.12%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y7.7%

GM growth 5Y11.01%

F-Score7

Asset Turnover0.42

Health

		Industry Rank	Sector Rank
Debt/Equity	0.37
Debt/FCF	N/A
Debt/EBITDA	4.73
Cap/Depr	179.9%
Cap/Sales	36.81%
Interest Coverage	N/A
Cash Conversion	298.64%
Profit Quality	N/A
Current Ratio	1.81
Quick Ratio	1.81
Altman-Z	4.29

F-Score7

WACC7.28%

ROIC/WACCN/A

Cap/Depr(3y)219.46%

Cap/Depr(5y)224.77%

Cap/Sales(3y)49.12%

Cap/Sales(5y)62.1%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)100%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%100%

EPS Next Y52.02%

EPS Next 2Y5.65%

EPS Next 3Y46.05%

EPS Next 5YN/A

Revenue 1Y (TTM)39.32%

Revenue growth 3Y46.7%

Revenue growth 5Y65.43%

Sales Q2Q%31.94%

Revenue Next Year31.7%

Revenue Next 2Y30.51%

Revenue Next 3Y33.84%

Revenue Next 5Y30.4%

EBIT growth 1Y41.86%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year258.01%

EBIT Next 3Y81.73%

EBIT Next 5Y48.14%

FCF growth 1Y55.15%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y349.62%

OCF growth 3Y61.83%

OCF growth 5YN/A

KNEAT.COM INC (KSI.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens